Skip to main content

Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 20, 2022

Elevance Health (NYSE: ELV) will release second quarter 2022 financial results on July 20, 2022, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

888-947-9963 (Domestic)

866-430-8797 (Domestic Replay)

312-470-0178 (International)

203-369-0943 (International Replay)

The access code for the call is 3972058. There is no access code for the replay. The replay will be available from 11:30 a.m. EDT on July 20, 2022 until the end of the day on August 20, 2022. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. A webcast replay will be available following the call.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The company supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on Twitter and Elevance Health on LinkedIn.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.95
-3.74 (-1.59%)
AAPL  267.02
-5.39 (-1.98%)
AMD  238.93
-7.88 (-3.19%)
BAC  51.76
-0.85 (-1.63%)
GOOG  285.40
+8.42 (3.04%)
META  600.07
-9.39 (-1.54%)
MSFT  506.82
-3.36 (-0.66%)
NVDA  185.07
-5.10 (-2.68%)
ORCL  216.14
-6.71 (-3.01%)
TSLA  407.09
+2.74 (0.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.